Bayesian Capital Management’s MetLife MET Stock Holding History

Bayesian Capital Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-52,531	Closed	-$3.69M	–	909
2024 Q2	$3.69M	Sell	52,531 -6,800	-11%	-$486K	0.42%	47
2024 Q1	$4.4M	Buy	59,331 +4,100	+7%	+$286K	0.42%	51
2023 Q4	$3.65M	Buy	55,231 +49,331	+836%	+$3.09M	0.39%	54
2023 Q3	$371K	Sell	5,900 -18,400	-76%	-$1.15M	0.04%	422
2023 Q2	$1.37M	Buy	+24,300	New	+$1.35M	0.15%	189
2022 Q2	–	Sell	-18,392	Closed	-$1.29M	–	961
2022 Q1	$1.29M	Buy	+18,392	New	+$1.24M	0.19%	151
2021 Q3	–	Sell	-12,500	Closed	-$748K	–	478
2021 Q2	$748K	Buy	+12,500	New	+$792K	0.2%	134
2020 Q1	–	Sell	-9,500	Closed	-$484K	–	896
2019 Q4	$484K	Sell	9,500 -12,036	-56%	-$581K	0.08%	314
2019 Q3	$1.02M	Buy	+21,536	New	+$1.03M	0.19%	140
2018 Q4	–	Sell	-24,779	Closed	-$1.16M	–	716
2018 Q3	$1.16M	Sell	24,779 -4,421	-15%	-$202K	0.19%	145
2018 Q2	$1.27M	Buy	+29,200	New	+$1.36M	0.29%	89
2018 Q1	–	Sell	-57,534	Closed	-$2.91M	–	734
2017 Q4	$2.91M	Buy	+57,534	New	+$3.03M	0.59%	21
2017 Q1	–	Sell	-13,599	Closed	-$653K	–	589
2016 Q4	$653K	Buy	+13,599	New	+$624K	0.16%	240

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Bayesian Capital Management's MET Position: Q3 2024 in Review

Bayesian Capital Management sold out of MetLife (MET) in Q3 2024, closing a stake of 52,531 shares — an estimated $3.69M sold.

Bayesian Capital Management first reported a position in MET in Q4 2016 and held it in 13 quarters. The position peaked at $4.4M in Q1 2024. 1,318 funds tracked by Wall St. Rank hold MET as of Q3 2024.

Bayesian Capital Management reported no remaining MetLife position as of Q3 2024 after selling out during the quarter.
Bayesian Capital Management sold 52,531 MetLife shares in Q3 2024, an estimated $3.69M.
Bayesian Capital Management first reported a position in MetLife in Q4 2016 and held it in 13 quarters.
Bayesian Capital Management's MetLife position peaked at $4.4M in Q1 2024.
1,318 funds tracked by Wall St. Rank held MetLife as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.